{
  "id": 199500,
  "title": "Revolution Medicines preps for launching pancreatic cancer drug, ups 2026 expenses",
  "url": "https://urgent.news/2026/08/06/revolution-medicines-preps-for-launching-pancreatic-cancer-drug-ups",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-06T01:31:29.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/revolution-medicines-preps-for-launching-pancreatic-cancer-drug-ups-2026-expenses/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Revolution Medicines executives say they're ready to launch what is arguably the biopharma industry's most highly anticipated experimental therapy. The drug, daraxonrasib, is awaiting an approval decision from the US and Europe for metastatic pancreatic ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}